IMMUNITYBIO, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- IMMUNITYBIO, INC. payments for repurchase of common stock for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- IMMUNITYBIO, INC. payments for repurchase of common stock for the quarter ending 2020-09-30 was $0.00.
- IMMUNITYBIO, INC. payments for repurchase of common stock for the quarter ending 2019-12-31 was $2.00M, a 777.19% increase year-over-year.
- IMMUNITYBIO, INC. payments for repurchase of common stock for the quarter ending 2019-09-30 was $0.00.
- IMMUNITYBIO, INC. payments for repurchase of common stock for fiscal 2021 was $0.00.
- IMMUNITYBIO, INC. payments for repurchase of common stock for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- IMMUNITYBIO, INC. payments for repurchase of common stock for fiscal 2019 was $2.50M, a 996.93% increase from fiscal 2018.
- IMMUNITYBIO, INC. payments for repurchase of common stock for fiscal 2018 was $228.00K, a 98.50% decline from fiscal 2017.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.50M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2018-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $228.00K 10-K · filed 2021-03-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.77M derived: sum of 4 quarters · filed 2020-03-25 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.77M derived: sum of 4 quarters · filed 2020-03-25 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-07 | $14.18M derived: sum of 4 quarters · filed 2020-03-25 |
| 2017-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $15.23M 10-K · filed 2020-03-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $16.41M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | $11.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $18.98M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-03-31 | $1.05M 10-Q · filed 2018-05-07 | $14.35M derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $15.85M 10-K · filed 2019-03-13 |
| 2016-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $11.90M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $6.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $9.32M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $2.55M 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $4.80M 10-K · filed 2018-03-12 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |